BioSpace3d
5 DMD Candidates to Watch in 2025
Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...
Gene therapies have been uneven for DMD — but these companies hope to turn the tide
Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the ...
The American Journal of Managed Care2d
EMBARK 2: Delandistrogene Moxeparvovec Shows Sustained Benefits in DMD
The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...
GlobalData on MSN2d
Roche reports positive topline outcomes from DMD treatment trial
Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...
biopharma-reporter2d
Roche’s Elevidys demonstrates significant benefits for DMD patients in Phase 3
The gene therapy improved motor functions in children with Duchenne muscular dystrophy two years after treatment ...
BioSpace3d
Duchenne Muscular Dystrophy Space on Cusp of Pivotal Era
While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...
The American Journal of Managed Care6d
Prophylactic Cardiac Medication May Prolong Survival in DMD
Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...
ENDPOINTS NEWS3d
Sarep­ta shares two-year DMD study da­ta that could in­form Eu­ro­pean ap­proval de­ci­sion
Sarepta Therapeutics unveiled new results from the second part of a clinical trial for its Duchenne muscular dystrophy gene ...
PGA Tour to test distance technology at multiple tournaments during 2025 season
Gary Young, the PGA Tour’s senior vice president of rules and competition, said players and fans have suggested they could ...
bangaloremirror.indiatimes8d
Toddler’s battle with DMD: Hope rests on gene therapy
According to Dr Ann Agnes Mathew, Consultant Pediatric Neurologist at Bangalore Baptist Hospital, DMD is life-threatening and ...
Business Wire8h
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for ...
DMD Ranks #27 as the Sole ITAD on the 2025 Real Leaders® Top Impact Companies List
DMD Systems Recovery, LLC (DMD), a leader in Reuse First™ IT Asset Disposition (ITAD) services and a Certified B Corporation, has been ranked #27 overall and #4 among technology companies on the 2025 ...